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Abstract
Background: Optical coherence tomography is a contactless and fast neuroimaging method. Previous Studies have observed thinning of the ganglion cell layer 
and inner plexiform layer in many neurodegenerative diseases. Objective: The aim of this study was to compare the layers of ganglion cell complex in conversion 
disorder. Methods: This study involved 50 conversion disorder patients and 50 healthy volunteers as the control. The parameters were measured and recorded 
automatically by a spectral optical coherence tomography device. Results: There was no difference in the retinal nerve fiber layers between the conversion dis-
order group and the control group (p > 0.05). The left and right choroid layer thickness acquired from three regions of the choroid layer was higher in patients 
compared with controls (p < 0.05). The ganglion cell layer and inner plexiform layer volumes were also significantly lower in the patient group (p < 0.05). Dis-
cussion: These ganglion cell layer and inner plexiform layer findings suggest that neurodegeneration occurs during the course of conversion disorder especially 
in subtype involved motor component. The choroid seems to be more related to the sensory component and it may be used to determine the active stage of the 
disease and to monitor inflammatory process like other inflammation markers used in systemic inflammatory diseases.
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Introduction
Conversion Disorder (CD) “involves unexplained symptoms or 
deficits affecting voluntary motor or sensory function” that cannot 
be attributed to an organic neurological cause. The symptoms of CD 
are thought to be generated unconsciously, arising from trauma, daily 
stressors, or conflict1. Symptoms suggest a medical condition with 
a behavioral presentation mimicking various types of neurological 
symptoms. 30% of neurological patients have neurological symptoms 
that cannot be explained medically2. The psychiatric approach to 
conversion movement disorder and the neurological approach to 
the psychogenic movement disorders are both problematic. Neither 
neurology nor psychiatry has yet made a clear interpretation of the 
possible mechanisms underlying this disorder. For this reason, a 
number of neurobiological and neuroimaging studies have been 
conducted in recent years to explain the etiopathogenesis of CD3.
Cellular, molecular, and structural pathologies of the limbic 
regions, amygdala, thalamus, and their interactions with different 
motor areas have been most commonly studied. These studies 
indicate abnormalities outside the core motor network, including the 
prefrontal cortex and anterior cingulate cortex. The results support 
the hypothesis of abnormal inhibition of motor systems by limbic 
regions or impairments of motor conceptualization. In addition, 
reduced thalamic, caudate, basal ganglia, and lentiform nuclei volume, 
increased amygdala activation have been reported in the cases of the 
CD. The studies suggested that patients with CD have smaller mean 
volumes of the right and left basal ganglia and smaller right thalamus, 
with a trend toward to smaller left thalamus compared to healthy 
controls. It is emphasized that this reduction may be important in 
understanding the pathophysiology of the CD. Brain volume loss has 
been observed in patients with CD, and these findings suggest that 
neurodegeneration accompanies with CD4. Another device that can be 
used to evaluate neurodegeneration is optical coherence tomography. 
Optical coherence tomography (OCT) is a novel imaging method 
that can capture biological tissue layers by acquiring high-resolution 
sections. This technique measures the delay time and intensity of 
infrared light, which is transmitted to and reflected from different 
tissue layers. It gives cross-sectional images of tissues similar to, but 
with much higher resolution than ultrasonography. The OCT method 
was first described by Fujimoto et al. from the Massachusetts Institute 
of Technology. Then, its use in ophthalmology and in neurology was 
described. Its use increased rapidly because it is a non-invasive and 
rapid method that can assess the macula thickness (MT), volume 
(MV) and retinal layers. Because OCT technology significantly 
enhances the imaging resolution, the segmentation of retinal layers, 
such as the ganglion cell layer (GCL), inner plexiform layer (IPL), and 
retinal nerve fiber layer (RNFL), is now possible. The RNFL involves 
axons of ganglion cells, the ganglion cell layer (GCL) involves bodies 
of ganglion cells, and the IPL involves dendrites of ganglion cells5,6.
Another parameter that can be measured with OCT is choroidal 
thickness. The choroid is among the most vascularized tissues in the 
human body, and it plays important roles in providing oxygen and 
nutrition to the outer retina, temperature regulation of the retina, 
disposition of waste products from the retina, and the release of 
growth factors. Thus, any vascular pathology can cause choroidal 
thinning. More recently, its use was expanded to neurodegenerative 
diseases because the retina is an anatomical extension of the brain, 
and retinal changes may occur in parallel with inflammation and CNS 
degeneration7,8. OCT has shown retinal changes in neurodegenerative 
diseases, such as multiple sclerosis8, Alzheimer’s disease9, Parkinson’s 
disease10, and restless leg syndrome11 which correlated with the 
severity of clinical disease. A demonstration of retinal neuronal 
loss using OCT provides great evidence for degeneration. Research 
on multiple sclerosis patients has repeatedly shown an association 
between retinal thinning and gray matter damage in the brain. 
Therefore, the thickness of the retinal layers has become an important 
anatomical parameter to track neurodegeneration12.
More recently OCT was used to detect neuronal degeneration 
in psychiatric disorders. Using time domain OCT Cabezon et al.13 
reported a significant reduction in the overall and superior quadrant 
RNFL thickness in schizophrenia patients compared with controls. 
The Spatial resolution of OCT devices increased with new spectral 
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domain OCT and this enabled separation of other retinal sublayers 
such as GCL and IPL was shown to have better structure-function 
correlation in neurodegenerative diseases such as multiple sclerosis 
then RNFL14. Our group demonstrated reduced GCL and IPL volumes 
in schizophrenia patients compared with controls using spectral 
OCT15. We also detected significant negative correlations between 
disease severity parameters and GCL and IPL volumes. In our another 
study, it is suggested that the neurodegeneration occurred during the 
course of bipolar disorder may be demonstrated by decreased GCL at 
early stages, and as the disease progresses, the involvement of other 
retinal layers, such as the RNFL and IPL, maybe observed16. Again, 
our research team demonstrated that OCT finding of decreased GCL 
and IPL volumes supports previous research suggesting degeneration 
in major depressive disorder. According to this study, considering 
RNFL to be the latest layer that will be affected during the course of 
degeneration, GCL and IPL volumes appear to be better parameters 
follow. In addition, choroid may be an important structure to detect 
acute attack period and to follow the inflammatory process in major 
depressive disorder like in systemic inflammatory diseases17. To the 
best of our knowledge, no study has assessed the OCT parameters 
(RNFL, GCL, IPL, and choroidal thickness) in patients with CD.
Although not a subtype classification based on Diagnostic and 
Statistical Manual of Mental Disorders (DSM), some authors preferred 
to distinguish conversion disorder according to symptoms18-20. In these 
studies, there was information that conversion symptoms may have 
emerged with different etiopathogenesis. Our hypothesis was that the 
symptoms of conversion disorder could be separated with the structures 
of eye. The aim of this study was to compare the RNFL, GCL, IPL, 
and choroidal thickness of patients with motor CD (M-CD, abnormal 
movements such as tremor, dystonia or weakness such as paraplegia) 
with somato-sensorial CD (SS-CD, represents the symptoms of 
sensory loss such as not seeing, not hearing) with sensori-motor CD 
(SM-CD) and controls to assess the usefulness the usefulness of these 
measurements to demonstrate neurodegeneration in CD.
Material and methods
Study sample
This case-control study compared patients with CD who were 
followed in the Psychiatry Department at our University Medical 
School with a control group. The patients with CD were consecutive 
patients who were being followed at our outpatient clinic at least 
for the last 6 months. The CD group consisted of 50 patients (10 
males and 40 females). In terms of subtypes; there were 19 M-CD 
patients, 20 SS-CD patients, and 11 SM-CD patients. After being seen 
during the baseline visit by the treating psychiatrist, each patient’s 
eligibility for the study was evaluated, and if they were eligible, they 
were invited to participate in the study. The control group consisted 
of 50 healthy volunteers without a history of a CD who were 
recruited from the hospital staff. OCT measurements were made in 
the Ophthalmology Department at our University Medical School. 
All OCT measurements were made between 10 am – 14 pm due to 
the operating time of the device. Local ethics committee approval 
was obtained, and all study participants provided written informed 
consent (Protocol Number: 2016/2-7).
Inclusion and exclusion criteria
Patients with CD who were between 18 and 65 years of age and 
who were diagnosed according to the DSM-IV-TR criteria1 
were included. Patients who had comorbid first axis diagnosis, 
hypertension, diabetes mellitus, severe neurological, immunological 
or systemic diseases (glaucoma or retinal diseases) were excluded. 
Patients with refraction errors ≥ 1 prism dioptre were also excluded. 
Both the patient and the control groups were examined in the 
ophthalmology clinic and best corrected visual acuity, intraocular 
pressure, slit lamb bio-microscopy, and fundus examination by 
eye dilatation was measured. Patients and controls with normal 
eye findings were included. The group of healthy controls did not 
have any first axis diagnosis, hypertension, diabetes mellitus, severe 
neurological, immunological or systemic diseases which may affect 
the results.
OCT measurements
A spectral-OCT device (SpectralisTM OCT, Version 6.0, Heidelberg 
Engineering, Germany) was used to assess the RNFL and choroid 
thicknesses and GCL and IPL volumes in both eyes. The RNFL 
includes temporal (T), nasal (N), temporo-superior (TS), temporo-
inferior (TI) and global (G) segments. Therefore, 7 measurements 
were made for each eye (i.e., N, NS, NI, T, TS, TI, G) (Figure 1). 
Figure 1. Measurement of RNFL thicknesses with spectral OCT.
A. The circle is drawn around the optic disc to measure peripapillary RNFL thickness. B. Demonstration of RNFL. C. Seven measurements are performed 
for each eye, providing the RNFL thickness of the TS, TI, T, NS, NI, N, and G sectors. D. RNFL thickness map.
OCT: Optical Coherence Tomography; RNFL: Retinal Nerve Fiber Layer; TS: Temporo-Superior; TI: Temporo-Inferior; T: Temporal; NS: Nasal Superior; 
NI: Nasal Inferior; N: Nasal; G: Global.
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The choroid structure was also measured with OCT. The 
choroidal thickness was measured manually. A perpendicular line 
was drawn subfoveal from the outer edge of the retinal pigment 
epithelium to the choroid-sclera junction. Two additional lines were 
drawn at the nasal and temporal sides at 500 µm intervals from the 
subfoveal line. The mean value of these 3 measures was accepted as 
the choroidal thickness. All measurements were performed by the 
same author (ASK) who was blinded to the diagnoses of the patients. 
The choroidal measurement method used with the spectral-OCT 
devices has been previously explained.
Lastly, we measured the GCL and IPL volumes with an OCT 
device. Segmentation of the retina into 6 layers (GCL, IPL, RNFL, 
inner nuclear layer, outer plexiform layer, outer nuclear layer) was 
performed automatically with the device (Figure 2). Because the 
between-group comparisons provided similar results for the right and 
left eyes, only the results of the right eye are provided in the tables 
and discussed to decrease the complexity of the tables.
OCT findings
When all the lower layers of RNFL were evaluated in both eyes; there 
was no difference in the RNFL layers between the CD group and the 
control group (p > 0.05) (Table 2).
The mean choroidal thickness, which is the mean value of the 
measurements from three regions, was significantly increased in the 
patients with CD compared with the controls (p < 0.05) (Table 2). The 
choroidal thickness of right eye in patients diagnosed with SS-CD 
was significantly higher than M-CD and SM-CD, but not significant 
for left eye’s choroid thickness (Figure 3).
The GCL and IPL volumes were significantly decreased in the 
patients with CD compared with the controls (p < 0.05) (Table 3). 
We found significantly lower GCL and IPL volumes in M-CD and 
SM-CD patients (p < 0.05). But, GCL and IPL volumes were not 
significantly lower in SS-CD patients when compared with M-CD 
and SM-CD patients (Table 4). There was no a significant decrease 
in GCL and IPL volumes in SS-CD patients when compared with 
control group (p < 0.05) (Table 5) (Figure 4).
Discussion
We found 3 main findings in imaging studies done with OCT device 
in the CD patients. One of the most important findings of our study 
was the lower volume of GCL and IPL volumes in CD patients 
compared with the controls for both eyes. Somas of the ganglion 
cells form GCL, dendrites of ganglion cells form IPL, and their axons 
form RNFL12,13. So our finding implies degeneration in somas and 
dendrites of the neurons in the retina. Axonal degeneration can be 
responsible for decreases in the gray matter volume and also the 
thinning of the RNFL. Nerve axons in the retina make synapses 
at the mesencephalon, lateral geniculate nucleus, pretectum, and 
hypothalamus. We wanted to investigate the retina by OCT method to 
find clues for neurodegeneration. Because the retina is accepted as an 
extension of the brain by many anatomists due to the embryological 
development and cellular structure7,21.
Figure 2. Measurement of the GCL and IPL thicknesses with spectral OCT.
GCL: Ganglion Cell Layer; IPL: Inner Plexiform Layer; RNFL: Retinal Nerve 
Fiber Layer; OCT: Optical Coherence Tomography.
Table 1. Sociodemographic features of the patients and the control groups
Patient Control P value
N = 50 % N = 50 %
Sex 0.483
Male 10 20 14 28
Female 40 80 36 72
Education 0.026
No 5 10 5 10
Primary school 21 42 7 14
Secondary school 6 12 11 22
High school 11 22 20 40
University 7 14 7 14
Occupation 0.000
No 17 34 18 36
Worker 2 4 19 38
Public servant 1 2 9 18
Farmer 1 2 1 2
Other (Housewife) 29 58 3 6
Marital Status 0.641
Married 38 76 34 68
Single 10 20 14 28
Divorced 2 4 2 4
Smoking 0.125
Yes 6 12 13 26
No 44 88 37 74
Statistical analyses
Statistical analyses were performed using SPSS 22.0 package program 
(IBM Corp). The mean ± standard deviation and percentages were 
used as descriptive statistics. The Chi2 test was used to compare 
categorical variables. The normality of the data was tested using the 
Kolmogorov-Smirnov test. An independent samples t-test was used 
to compare 2 normally distributed variables and the Mann-Whitney 
U test was used to compare 2 non-normally distributed variables. 
ANOVA and post-hoc Tukey’s B test were used to compare more 
than two normally distributed variables. The Kruskal-Wallis test was 
used to compare more than two non-normally distributed variables. 
P < 0.05 indicated statistical significance.
Results
Socio-demographic data
The mean patient ages in the CD group and control groups were 
35.68 ± 12.03 and 37.96 ± 15.88 years, respectively and it was not 
significant (p = 0.420). The socio-demographic features of the 
patients and controls are shown in Table 1. There were no statistically 
significant differences between the groups, according to sex, marital 
status, and smoking. Education was significantly higher in the control 
group than in the patient group (p < 0.05). Occupation status was 
also significantly higher in the control group than in the patient 
group (p < 0.05). In the CD group, there were a family history in 9 
(%18) patients and 41 (%82) not. The mean disease duration was 
10.52 ± 9.10 in the CD group. Number of hospitalizations; none: 41 
patients (%82), < 3: 6 (%12), and > 3: 3 (%6). When we divide the 
conversion patients into 3 subtypes according to the predominant 
symptom clusters. The number of M-CD patients was 19 (38%), the 
number of SS-CD patients were 20 (40%) and the number of SM-CD 
patients was 11 (22%).
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Figure 3. Comparison of choroidal thickness of CD subtypes.
Comparison of choroidal thickness of a patient with M CD (A), a patient 
with SM-CD (B), a patient with SS-CD (C), and a control (D) (CD: Conversion 
Disorder; M CD: Motor Conversion Disorder; SM-CD: Sensori-Motor Conver-
sion Disorder; SS-CD: Somato-Sensorial Conversion Disorder).




± SD)  
P value
Right GCL 1.12 ± 0.99 μm 1.20 ± 0.47 μm 0.000
Left GCL 1.11 ± 0.97 μm 1.20 ± 0.47 μm 0.000
Right IPL 0.91 ± 0.73 μm 0.96 ± 0.50 μm 0.000
Left IPL 0.91 ± 0.75 μm 0.96 ± 0.50 μm 0.000
GCL: Ganglion Cell Layer, IPL: Inner Plexiform Layer, SD: Standard Deviation.
Table 2. Mean values for RNFL and choroid thickness 
Patients (Mean ± SD) Controls (Mean ± SD)  P value
Right nasal superior/Left nasal superior 116,18 ± 23,51 μm/122,86 ± 27,91 μm 112,60±19,49 μm/124,88±20,43 μm 0.409/0.681
Right nasal inferior/Left nasal inferior 130,08 ± 23,40 μm/132,52 ± 25,24 μm 127,78 ± 27,32 μm/123,84 ± 27,11 μm 0,652/0.146
Right nasal/Left Nasal 84,40 ± 17,85 μm/83,28 ± 18,68 μm 83,54 ± 15,88 μm/78,02 ± 14,69 μm 0.800/0.121
Right temporal/Left temporal 72,86 ± 14,53 μm/71,54 ± 13,47 μm 75,34 ± 8,62 μm/73,348 ± 9,16 μm 0.302/0.402
Right temporal inferior/Left temporal inferior 147,60 ± 22,87 μm/149,12 ± 26,33 μm 154,70 ± 17,55 μm/154,24 ± 20,16 μm 0.085/0.278
Right temporal superior/Left temporal superior 145,52 ± 25,96 μm/144,68 ± 20,19 μm 145,76 ± 14,77 μm/146,78 ± 14,16 μm 0.955/0.548
Right global/Left global 106,32 ± 11,09 μm/106,94 ± 11,15 μm 107,32 ± 8,82 μm/106,92 ± 10,25 μm 0.619/ .993
Right choroid mean/Left choroid mean 310,60 ± 54,11 μm/298,90 ± 55,31 μm 249,16 ± 31,67 μm/247,66 ± 37,02 μm 0.000/0.000





In this study, we found a retinal nerve cell damage and neuronal 
degeneration in patients with CD. There are some studies that point 
to the findings of neurodegeneration in CD patients. Volumetric 
MR studies have found evidence for neurodegeneration in the 
brains of patients with CD4. Atmaca et al.4 suggested that patients 
with CD have significantly smaller mean volumes of the left 
and right basal ganglia and smaller right thalamus, with a trend 
toward to smaller left thalamus compared to healthy controls. The 
demonstration of decreased activity in some areas of the brain 
in single photon emission computed tomography (SPECT) and 
functional magnetic resonance imaging studies is important in 
supporting neuropathological processes in the brain. In one of the 
studies related to cerebral blood flow, Czarnecki et al.22 compared 
conversive tremor with essential tremor using SPECT at rest and 
during a tremor-inducing motor task (to bring a cup from a table 
to the face). During the motor task, patients with functional tremor 
had decreased regional cerebral blood flow in the ventromedial 
prefrontal cortex consistent with abnormalities of the default mode 
network, which were not observed in essential tremor. According to 
the study of Schrag et al.23, psychogenic dystonia was associated with 
greater basal ganglia and cerebellar and decreased primary motor 
cortical blood flow, compared with healthy volunteers and patients 
with organic dystonia.
The second remarkable finding of our study is differences 
between subtypes of CD in terms of GCL and IPL. We found 
significantly lower GCL and IPL volumes in M-CD and SM-CD 
patients. But, GCL and IPL volumes were not significantly lower in 
SS-CD patients when compared with motor and SM-CD patients. 
There was no a significant decrease in GCL and IPL volumes in 
SS-CD patients when compared with control group. So; Neuronal 
degeneration in M-CD and SM-CD patients were found to be 
significantly higher than the control group, but no neuronal loss 
in SS-CD was found. This finding suggests that a more destructive 
etiopathogenesis is responsible for neuronal damage in the motor 
component dominant CD. Indeed, in the study of Voon et al.24, 
some neurological findings were pointed out in CD patients with 
psychogenic movement disorder. The studies reveal abnormalities 
outside the core motor network, including the anterior cingulate 
cortex and prefrontal cortex. These findings support the hypothesis 
of impairments of motor conceptualization or abnormal inhibition 
of motor systems by limbic regions25,26. The result of all these studies 
suggests that neurological deficit is predominant in M-CD.
The third important finding of our study is changes in choroid 
thickness in CD patients. The choroid is one of the most vascularized 
tissues of the human body and it plays important roles in nutrition 
and oxygenation of outer retina, disposal of waste products out of 
retina and secretion of growth factors27. Choroid tissue is affected by 
any inflammatory or autoimmune conditions affecting blood flow. 
Research in some autoimmune diseases with retinal involvement (e.g. 
Behçet’s disease) also demonstrated that choroid thickness increases 
during acute attack periods due to increased inflammation but 
then decreases with progressing disease28. We detected a significant 
increase in choroid thickness in CD patients who did not have any 
systemic disease that can disturb the vascular structure of affect blood 
flow when compared with. In addition, the choroidal thickness of 
right eye in patients diagnosed with SS-CD was significantly higher 
than M-CD and SM-CD, but not significant for left eye’s choroid 
thickness. We suggest that an increase in choroid thickness results 
from the inflammatory process in the CD. Inflammatory process has 
been demonstrated in many psychiatric disorders such as obsessive 
compulsive disorder and depression. Because CD occurs in response 
to psychosocial stress, neural plasticity promises hope in explaining 
the effect of stress on brain29. One candidate mechanism that has 
been proposed as the site of possible flaw in signal transduction 
from monoamine receptors is the target gene for brain-derived 
neurotrophic factor. Deveci et al.30 demonstrated that the serum 
BDNF level of the healthy control group was statistically higher 
than the level of the CD group. Inflammation in the central nervous 
system is known to cause glial degeneration and this process is 
blamed in the etiology of Alzheimer’s disease, and Parkinson’s disease. 
Studies in psychoneuroimmunology yielded strong evidence that 
the nervous and immune systems are in interaction reciprocally31. 
These intercorrections are mainly mediated by hormones, neural 
activations, and cytokines. Tiyekli et al.32 suggested that lower TNF-α 
levels were found during acute conversion phase. They stated that 
stress associated with CD may suppress immune function in acute 
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Table 4. Comparison of GCL, IPL, and choroidal thickness in right and left eyes in conversion subtypes
Subtypes (I) Patient (Mean ± SD) Subtypes (J) Mean Difference (I-J) P value
Right GCL M-CD* (n = 19) 1.06 ± 0.42 μm SS-CD -0.14726 0.000
SM-CD -0.01254 0.645
SS-CD* (n = 20) 1.21 ± 0.82 μm M-CD 0.14418 0.000
SM-CD 0.13777 0.000
SM-CD* (n = 11) 1.07 ± 0.54 μm SS-CD -0.13473 0.000
M-CD 0.01254 0.645
Left GCL M-CD (n = 19) 1.05 ± 0.63 μm SS-CD -0.14418 0.000
SM-CD -0.00641 0.856
SS-CD (n = 20) 1.20 ± 0.47 μm M-CD 0.10242 0.000
SM-CD 0.09491 0.000
SM-CD (n = 11) 1.06 ± 0.12 μm SS-CD -0.13777 0.000
M-CD 0.00641 0.856
Right IPL M-CD (n = 19) 0.87 ± 0.65 μm SS-CD -0.10242 0.000
SM-CD -0.00751 0.724
SS-CD (n = 20) 0.97 ± 0.21 μm M-CD 0.09363 0.000
SM-CD 0.09282 0.000
SM-CD (n = 11) 0.87 ± 0.34 μm SS-CD -0.09491 0.000
M-CD 0.00751 0.724
Left IPL M-CD (n = 19) 0.87 ± 0.50 μm SS-CD -0.09363 0.000
SM-CD -0.00081 0.972
SS-CD (n = 20) 0.97 ± 0.47 μm M-CD 0.09363 0.000
SM-CD 0.09282 0.000
SM-CD (n = 11) 0.87 ± 0.50 μm SS-CD -0.09282 0.000
M-CD 0.00081 0.972
Right Choroid M-CD (n = 19) 288.94 ± 37.16 μm SS-CD -41,45263 0.016
SM-CD -23,05263 0.247
SS-CD (n = 20) 330.40 ± 23.25 μm M-CD 41,45263* 0.016
SM-CD 18,40000 0.350
SM-CD (n = 11) 312.00 ± 54.17 μm SS-CD -18,40000 0.350
M-CD 23,05263 0.247
Left Choroid M-CD (n = 19) 295.57 ± 57.34 μm SS-CD -7,92105 0.663
SM-CD -0.69378 0.974
SS-CD (n = 20) 303.50 ± 32.74 μm M-CD 7,92105 0.663
SM-CD 7,22727 0.734
SM-CD (n = 11) 296.27 ± 58.12 μm SS-CD -7,22727 0.734
M-CD 0.69378 0.974
M-CD*: Motor Conversion Disorder; SS-CD*: Somato-Sensorial Conversion Disorder; SM-CD*: Sensori-Motor Conversion Disorder; SD: Standard Deviation; GCL: Ganglion Cell Layer; IPL: Inner Plexiform Layer.
Table 5. Comparison of GCL and IPL Volumes of Somato-Sensorial Conver-




(Mean ± SD)  
P value
Right GCL 1.21 ± 0.54 μm 1.20 ± 0.47 μm 0.540
Left GCL 1.20 ± 0.97 μm 1.20 ± 0.47 μm 0.474
Right IPL 0.97 ± 0.52 μm 0.96 ± 0.50 μm 0.522
Left IPL 0.97 ± 0.60 μm 0.96 ± 0.50 μm 0.606
SS-CD: Somato-Sensorial Conversion Disorder; SD: Standard Deviation; GCL: Ganglion Cell Layer; 
IPL: Inner Plexiform Layer.
Figure 4. Comparison of GCL of CD subtypes.
Comparison of GCL volumes of a patient with M CD (A), a patient with SM-CD 
(B), a patient with SS-CD (C), and a control (D) (GCL: Ganglion Cell Layer; CD: 
Conversion Disorder; M CD: Motor Conversion Disorder; SM-CD: Sensori-
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conversion phase and may have diagnostic and therapeutic value. 
We think that inflammatory process is active in patients with CD 
in symptomatic phase causing increased blood flow and increasing 
choroid thickness. Furthermore, the more significant increase in 
choroidal thickness in the somato-sensorial CD suggests that the 
inflammatory etiopathogenesis may play a more prominent role in 
the somato-sensorial subtype. The choroid thickening of the somato-
sensorial CD and the direct retinal neuron damage of the motor CD 
and sensori-motor CD suggests the question of whether the subtypes 
differ in terms of etiopathogenesis. These results have led to the 
impression that the different clinical patterns of conversion disorder 
behave differently in terms of neurobiology. The cells involved in 
degeneration are mainly macrophages. Molecular inflammatory 
mediators such as cytokines, transcription factors, complement 
system, arachidonic acid metabolites, and oxidative stress parameters 
are also known to play a role in this mechanism33. Oxidative stress 
is mostly related to the increased formation of reactive oxygen 
and nitrogen species (ROS and RNS), which transmogrify the 
phospholipids and proteins leading to lipid peroxidation. These 
changes are considered to the change membrane permeability and 
configuration in addition to producing functional modification of 
various cellular proteins. Oxidative stress can cause to some cellular 
defects such as decreasing of the sarcolemmal Ca+2 ATP-ase pump 
and Na+-K+ ATP-ase activities. These alterations lead to a decrease 
in the Ca+2 effluxes and an increase in the Ca+2 influxes, respectively. 
Oxidative stress has also been reported to suppress the sarcoplasmic 
reticulum Ca+2 ATP-ase pump and thus inhibits Ca+2 sequestration 
from the cytoplasm. ROS change the activity of Ca+2 regulatory 
mechanisms and this results in intracellular Ca+2 overload and cell 
death34. In these findings from different part of literature, somatic 
subtypes were thought to use more inflammatory processes, whereas 
motor subtypes were thought to use mechanisms that could lead 
to more direct neuronal damage. Though there is no significant 
difference in GCL and IPL volumes between the motor subtype 
and the sensori-motor subtype, the sensorimotor subtype was less 
affected than the motor type, suggesting that the thinning probably 
originated only from the motor component.
When all the lower layers of RNFL were evaluated in both eyes; 
there was no difference in the RNFL layers between the CD group 
and the control group. We have one possible explanation for this. 
Previous studies have found that RNFL damage can be detected by 
ophthalmologic examination only after 50% of the ganglion cells 
were damaged35,36. Therefore, RNFL damage may be expected to 
occur after more ganglion cell damage takes place. To detect such 
a process longitudinal studies should be performed in CD patients 
involving early-stage patients.
In conclusion, the findings of this study suggest that there is 
neuronal degeneration in CD and that it can be characterized by 
the thinning of the GCL and IPL. This thinning is more significant 
in CD patients involve motor component. Moreover, choroid may 
be used to determine the active stage of the disease and to monitor 
inflammatory process like other inflammation markers used in 
systemic inflammatory diseases.
Limitations 
The major limitation of this study is its cross-sectional design. A 
prospective design starting from early periods of disease with regular 
follow-up OCT measurements would yield more convincing results 
about progressive degenerating nature of CD. There is a need for 
study that equals male and female subjects and control numbers. 
Another limitation of our study is lack of control measurements to 
increase validity and reliability of OCT to detect inflammation and 
degeneration. The inclusion of other neuroimaging methods such 
as magnetic resonance imaging to detect neurodegeneration and 
inflammatory markers such as interleukins or acute phase reactants to 
detect inflammation in future studies will provide better clues about 
the utility of OCT as a tool in neuropsychiatric disorders. Separation 
of patients into subgroups is another limitation because there is no 
classification system, since it is connected to the psychiatrist. The 
OCT application time can be clearer. Deep chamber, thick lens and 
axial length parameters are considered to be able to influence the 
measurements made and their absence is considered as a limitation. 
The fact that the medical treatment of the patient group is not known 
clearly is a limitation of this study. Effects of psychotropic medications 
on OCT measurements has not been studied in detail previously. 
Direct effects of psychotropic medications on the retina cannot be 
excluded and this should be assessed in further studies.
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10.1080/24750573.2018.1464273.
Financial disclosures
All authors report no financial interests or potential conflicts of 
interest.
Conflict of Interest
The authors declare that they have no competing interest.
Acknowledgments
The funding entities had no role in the design of the study, the 
collection and analysis of data, the decision to publish, or preparation 
of the manuscript.
References
1. American Psychiatric Association, 2000. Diagnostic and statistical 
manual of mental disorders, 4th ed., Washington, DC: American Psy-
chiatric Association [text revision].
2. Carson AJ, Ringbauer B, Stone J, McKenzie L, Warlow C, Sharpe M. Do 
medically unexplained symptoms matter? A prospective cohort study of 
300 new referrals to neurology outpatient clinics. J Neurol Neurosurg 
Psychiatry. 2010;68:207-10.
3. Aybek S, Nicholson TR, O’Daly O, Zelaya F, Kanaan RA, David AS. 
Emotion-Motion Interactions in Conversion Disorder: An fMRI Study. 
PLoS ONE. 2015;10(4):e0123273.
4. Atmaca M, Aydin A, Tezcan E, Poyraz AK, Kara B. Volumetric inves-
tigation of brain regions in patients with conversion disorder. Prog 
Neuropsychopharmacol Biol Psychiatry. 2006;30:708-13.
5. Fujimoto JG. Optical coherence tomography for ultrahigh resolution in 
vivo imaging. Nat Biotechnol. 2003;21:1361-7.
6. Fujimoto JG, Hee MR, Huang D, et al. Principles of optical coherence 
tomography. In: Schuman JS, Puliafito CA, and Fujimoto JG, editors. 
Optical coherence tomography of ocular diseases. Thorofare, NJ: Slack 
Inc.; 2004. p. 3-20.
7. Schönfeldt-Lecuona C, Kregel T, Schmidt A, Pinkhardt EH, Lauda F, 
Kassubek J, et al. From imaging the brain to imaging the retina: optic 
coherence tomography in schizophrenia. Schizophr Bull. 2016;42(1):9-14.
8. Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrel SK, et al. 
Primary retinal pathology in multiple sclerosis as detected by optical 
coherence tomography. Brain. 2011;134:518-33.
9. He XF, Liu YT, Peng C, Zhang F, Zhuang S, Zhang JS. Optical coherence 
tomography assessed retinal nerve fiber layer thickness in patients with 
Alzheimer’s disease: a meta-analysis. Int J Ophthalmol. 2012;5:401-5.
10. Cetin EN, Bir LS, Sarac G, Yaldizkaya F, Yaylali V. Optic disc and retinal 
nerve fibre layer changes in Parkinson’s disease. J Neuroophthalmol. 
2013;37:20-3.
11. Tak AZA, Celik M, Kalenderoglu A, Saglam S, Altun Y, Gedik E. 
Evaluation of optical coherence tomography results and cognitive func-
tions in patients with restless legs syndrome. Arch Neuropsychiatry. 
DOI:10.5152/npa.2017.21598.
12. Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome SD, 
et al. Optical coherence tomography reflects brain atrophy in multiple 
sclerosis: a four-year study. Ann Neurol. 2015;78(5):801-3.
160 Karadag AS et al. / Arch Clin Psychiatry. 2018;45(6):154-60
13. Cabezon L, Ascaso FJ, Ramiro P, Quintanilla MA, Gutieerrez L, Lobo 
A, et al. Optical coherence tomography: a window into the brain of 
schizophrenic patients. Acta Ophthalmol. 2012;90:0.
14. Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, et al. 
Visual dysfunction in multiple sclerosis correlates better with optical 
coherence tomography derived estimates of macular ganglion cell layer 
thickness than peripapillary retinal nerve fiber layer thickness. Mult 
Scler. 2011;17(12):1449-63.
15. Celik M, Kalenderoglu A, Sevgi-Karadag A, Egilmez OB, Han-Almis 
B. Decreases in ganglion cell layer and inner plexiform layer volumes 
correlate better with disease severity in schizophrenia patients than 
retinal nerve fiber layer thickness: findings from spectral optic coherence 
tomography. Eur Psychiatry. 2016;19(32):9-15.
16. Kalenderoglu A, Sevgi-Karadag A, Celik M, Egilmez OB, Han-Almis 
B, Ozen ME. Can the retinal ganglion cell layer (GCL) volume be a 
new marker to detect neurodegeneration in bipolar disorder? Compr 
Psychiatry. 2016;67:66-72.
17. Kalenderoglu A, Celik M, Sevgi-Karadag A, Egilmez OB. Optic coherence 
tomography shows inflammation and degeneration in major depres-
sive disorder patients correlated with disease severity. J Affect Disord. 
2016;204:159-65.
18. Scott RL, Anson JG. Neural correlates of motor conversion disorder. 
Motor Control. 2009;13(2):161-84.
19. Stone J, Carson A, Aditya H, Prescott R, Zaubi M, Warlow C, et al. The 
role of physical injury in motor and sensory conversion symptoms: a 
systematic and narrative review. J Psychosom Res. 2009;66(5):383-90.
20. Watanabe T, Akiyama K. Conversion disorder with sensory symptom or 
defect. Ryoikibetsu Shokogun Shirizu. 2003;38:515-8.
21. Bora E, Fornito A, Pantelis C, Yucel M. Gray matter abnormalities in 
major depressive disorder: a meta analysis of voxel based morphometry 
studies. J Affect Disord. 2012;138:9-18.
22. Czarnecki K, Jones DT, Burnett MS, Mullan B, Matsumoto JY. SPECT 
perfusion patterns distinguish psychogenic from essential tremor. Par-
kinsonism Relat Disord. 2011;17:328-32.
23. Schrag AE, Mehta AR, Bhatia KP, Brown RJ, Frackowiak RS, Trimble 
MR, et al. The functional neuroimaging correlates of psychogenic versus 
organic dystonia. Brain. 2013;136:770-81.
24. Voon V, Cavanna AE, Coburn K, Sampson S, Reeve A, LaFrance WC Jr. 
Functional neuroanatomy and neurophysiology of functional neurologi-
cal disorders (Conversion disorder). J Neuropsychiatry Clin Neurosci. 
2016;28(3):168-90.
25. Burgmer M, Konrad C, Jansen A, Kugel H, Sommer J, Heindel W, et al. 
Abnormal brain activation during movement observation in patients 
with conversion paralysis. Neuroimage. 2006;29:1336-43.
26. Ward NS, Oakley DA, Frackowiak RS, Halligan PW. Differential brain 
activations during intentionally simulated and subjectively experienced 
paralysis. Cogn Neuropsychiatry. 2003;8:295-312.
27. Parver LM. Temperature modulating action of choroidal blood flow. Eye 
(Lond). 1991;5:181-5.
28. Coskun E, Gurler B, Pehlivan Y, Kisacik B, Okumus S, Yayuspayi R, et 
al. Enhanced depth imaging optical coherence tomography findings in 
Behcet disease. Ocul Immunol Inflamm. 2013;3:1-6.
29. Maes M. The cytokine hypothesis of depression: inflammation, oxidative 
& nitrosative stress (IO&NS) and leaky gut as new targets for adjunc-
tive treatments in depression. Neuro Endocrinol Lett. 2008;29:287-91.
30. Deveci A, Aydemir O, Taskin O, Taneli F, Esen-Danaci A. Serum brain-
derived neurotrophic factor levels in conversion disorder: Comparative 
study with depression. Psychiatry Clin Neurosci. 2007;61:571-3.
31. Irwin MR. Human psychoneuroimmunology: 20 years of discovery. 
Brain Behav Immun. 2008;22:129-39.
32. Tiyekli UC¸ Aliyurt O, Tiyekli ND. Proinflammatory cytokine levels in pa-
tients with conversion disorder. Acta Neuropsychaitr. 2013;25(3):137-43.
33. Cámara-Lemarroy CR, Guzmán-de la Garza FJ, Fernández-Garza NE. 
Molecular inflammatory mediators in peripheral nerve degeneration and 
regeneration. Neuroimmunomodulation. 2010;17(5):314-24.
34. Parlakpinar H, Orum MH, Sagir M. Pathophysiology of myocardial isch-
emia reperfusion injury: A review. Medicine Science. 2013;2(4):935-54.
35. Honrubia F, Calonge B. Evaluation of the nerve fiber layer and peripapil-
lary atrophy in ocular hypertension. Int Ophthalmol. 1989;13:57-62.
36. Quigley HA, Addicks EM. Quantitative studies of retinal nerve fiber layer 
defects. Arch Ophthalmol. 1982;100:807-14.
